Regeneron COVID-19 therapy, U.K private-sector output, Google’s fiber-optic network, and New York stimulus benefits – what you’ve missed at the week start?
Global Insights
U.K stocks were weighed down by a slump in private sector growth, which fell to a 5-month low of 47.4 in November, below October’s 52.1 level
On fiscal policy, New York City mayor claimed that the residents received $40 billion in stimulus benefits to recover from the coronavirus.
The morning premarket mover was Regeneron, which announced it had received Emergency Use Authorization for REGN-COV2, a therapy for treating early COVID-19 symptoms. The stock rose 5.09% on the announcement and returned back at the open.
S&P 500 3,565.25 +0.31%
NASDAQ 11,880.00 -0.22%
DJIA 29,453.00 +0.83%
FTSE 6,333.84 -0.28%
DAX 13,158.00 +0.26%
NIKKEI 25,940.00 +0.76%
HSI 26,486.20 +0.13%
SHANGHAI 3,414.49 +1.09%
VIX 24.00 -1.54%
WTI Oil 43.09 +1.58%
Nat Gas 2.820 +6.53%
GOLD 1834.80 -2.01%
US Dollar Index 92.556 +0.21%
U.S. 10 Treasury Yield +0.83%
Corporate Stories
- Google announces that it is installing a fiber-optic network linking India to Europe and will connect via Saudi Arabia and Israel
Market Sentiment
- The market was mixed on Monday. Gold plunged while oil prices gained on continuing vaccine developments, as the VIX also fell. U.S. dollar index gained today on recovering economy, overshadowing optimism on vaccine roll-outs.
